AIS

Clinical trials for AIS explained in plain language.

Never miss a new study

Get alerted when new AIS trials appear

Sign up with your email to follow new studies for AIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1

New stroke drug aims to cut disability in first 3 hours

Disease control Recruiting now

This phase 3 trial tests whether a single injection of BXOS110, given within 3 hours of an acute ischemic stroke, can reduce overall disability compared to a placebo. About 1112 adults aged 18-85 with moderate to severe stroke are being enrolled. The main goal is to see if more p…

Matched conditions: AIS

Phase: PHASE3 • Sponsor: Biocells (Beijing) Biotech Co.,Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC

AIS

Get alerted when new AIS trials appear

New stroke drug aims to cut disability in first 3 hours